1996
DOI: 10.1016/s0002-9378(96)70392-7
|View full text |Cite
|
Sign up to set email alerts
|

Decreasing the cesarean section rate in a private hospital: Success without mandated clinical changes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
46
1
3

Year Published

1997
1997
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(52 citation statements)
references
References 19 publications
2
46
1
3
Order By: Relevance
“…Payment mechanisms to physicians and hospitals have also been shown to be one of key elements in multifaceted approaches that have proven effective in reducing CD rates in some cases [58,59] .…”
Section: Reforming Payment Mechanismsmentioning
confidence: 99%
“…Payment mechanisms to physicians and hospitals have also been shown to be one of key elements in multifaceted approaches that have proven effective in reducing CD rates in some cases [58,59] .…”
Section: Reforming Payment Mechanismsmentioning
confidence: 99%
“…Ein extrinsischer Faktor im Zusammenhang mit der erhöhten Zahl vaginal-operativer Eingriffe bei Geburten unter PDA wird mit dem "physician factor" bezeichnet. Dabei wird postuliert, dass das Vorgehen des Geburtshelfers prinzipiell durch die Realisierung einer Schmerzfreiheit durch eine PDA beeinflusst wird, wenngleich die Zahlen der Eingriffe mit den Zahlen der PDA nicht korrelieren [3,13,19]. Die Gründe für die Akzeptanz oder Ablehnung einer PDA sind sicherlich vielschichtig.…”
Section: Originalarbeit 23unclassified
“…In one trial, at three years disability (as assessed by the expanded disability scale scoring system) had worsened less in aggregate in the cohort treated with high dose interferon beta than in the cohort treated with placebo. 4 The difference was significant. A favourable effect of interferon beta-1b on disability has been shown, albeit less convincingly than might have been wished.…”
Section: Current Policy Is Sensiblementioning
confidence: 89%
“…Interferon beta-1b was shown in the five year pivotal trial in relapsingremitting multiple sclerosis to reduce the rate of severe relapses by one half and the overall relapse rate by one third. 4 Studies have highlighted the fact that relapses can have a profound effect on the quality of life of people with multiple sclerosis and their carers (data on file). Additionally, patients who received interferon beta-1b in the pivotal trial showed no increase in total lesion load on magnetic resonance imaging over five years, compared with an increase of about 30% in the placebo group.…”
Section: Interferon Beta Reduces Overall Relapse Rate By One Thirdmentioning
confidence: 99%